Erasca, Inc.
Status: Publicly traded
Direct answer
Erasca, Inc. is publicly traded on NASDAQ under the ticker ERAS.
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid...
Can you invest in Erasca, Inc.?
Yes. Erasca, Inc. trades publicly on NASDAQ as ERAS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Erasca, Inc.
Detailed equity research is provided by MarketSnap.